Skip to main content
2026 CRT Conference Main banner

CRT 2026

Spotlight

Session:: Beyond the Guidelines | Aortic Valve: Bicuspid | Lifetime Management | Redo Versus Explant | Asymptomatic Aortic Stenosis

What Does the Data Tell us on Redo TAVR?

Saturday, March 7, 2026
4:32 PM - 4:40 PM EST

    Speaker(s)

  • Gilbert H L Tang, MD, MSc, MBA

    Surgical Director, Structural Heart Program
    Mount Sinai Health System
    New York, New York, United States

    Disclosure(s): Abbott Structural Heart: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); JenaValve Technology Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Peija Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shenqi Medical Technology: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)